Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Absci Corporation
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
April 16, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 28, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
March 21, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
March 01, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Announces Pricing of Public Offering of Common Stock
February 27, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Announces Proposed Public Offering of Common Stock
February 27, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
February 21, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in Upcoming Investor Conferences
February 20, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
January 10, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the 26th Annual Needham Growth Conference
January 03, 2024
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
December 20, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
December 04, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 15, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
November 14, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
November 14, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
DE
Absci to Participate in Upcoming Investor Conferences
October 26, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
September 21, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Host R&D Day on October 4, 2023
September 06, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in Upcoming Investor Conferences
August 28, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
August 14, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
August 14, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
August 10, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
August 01, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
June 15, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
June 06, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
May 15, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
May 11, 2023
From
Absci Corporation
Via
GlobeNewswire
Tickers
ABSI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.